Kavar Capital Partners Group’s Medtronic MDT Stock Holding History

Kavar Capital Partners Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-820	Closed	-$80K	–	325
2019 Q2	$80K	Buy	+820	New	+$74.9K	0.03%	182
2018 Q3	–	Sell	-511	Closed	-$44K	–	274
2018 Q2	$44K	Sell	511 -107	-17%	-$8.94K	0.02%	196
2018 Q1	$50K	Buy	+618	New	+$51K	0.03%	185
2016 Q1	–	Sell	-380	Closed	-$29K	–	264
2015 Q4	$29K	Sell	380 -22	-5%	-$1.66K	0.02%	197
2015 Q3	$26K	Sell	402 -1	-0.2%	-$74	0.02%	206
2015 Q2	$29K	Buy	+403	New	+$30.8K	0.02%	213

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kavar Capital Partners Group's MDT Position: Q3 2019 in Review

Kavar Capital Partners Group sold out of Medtronic (MDT) in Q3 2019, closing a stake of 820 shares — an estimated $80K sold.

Kavar Capital Partners Group first reported a position in MDT in Q2 2015 and held it in 6 quarters. The position peaked at $80K in Q2 2019. 1,644 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

Kavar Capital Partners Group reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
Kavar Capital Partners Group sold 820 Medtronic shares in Q3 2019, an estimated $80K.
Kavar Capital Partners Group first reported a position in Medtronic in Q2 2015 and held it in 6 quarters.
Kavar Capital Partners Group's Medtronic position peaked at $80K in Q2 2019.
1,644 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Kavar Capital Partners Group's 13F filing for Q3 2019, filed 12 Nov 2019.